Gregory J. del Zoppo

Active 1986–2023

91
Papers
28,195
Citations
83
h-index
91
i10-index

Citations

Citations per year for Gregory J. del Zoppo1986: 3 citations1987: 4 citations1988: 10 citations1989: 7 citations1990: 10 citations1991: 5 citations1992: 28 citations1993: 20 citations1994: 64 citations1995: 99 citations1996: 122 citations1997: 115 citations1998: 163 citations1999: 172 citations2000: 172 citations2001: 218 citations2002: 237 citations2003: 244 citations2004: 232 citations2005: 252 citations2006: 272 citations2007: 267 citations2008: 248 citations2009: 261 citations2010: 201 citations2011: 249 citations2012: 254 citations2013: 216 citations2014: 186 citations2015: 219 citations2016: 170 citations2017: 189 citations2018: 194 citations2019: 627 citations2020: 610 citations2021: 569 citations2022: 397 citations2023: 298 citations2024: 446 citations2025: 173 citations2026: 10 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,603 citing papers, 29.5% of this breakdownChina: 881 citing papers, 10% of this breakdownGermany: 605 citing papers, 6.9% of this breakdownUnited Kingdom: 574 citing papers, 6.5% of this breakdownCanada: 408 citing papers, 4.6% of this breakdownAustralia: 323 citing papers, 3.7% of this breakdownFrance: 296 citing papers, 3.4% of this breakdownJapan: 256 citing papers, 2.9% of this breakdownItaly: 253 citing papers, 2.9% of this breakdownSpain: 222 citing papers, 2.5% of this breakdownSwitzerland: 211 citing papers, 2.4% of this breakdownNetherlands: 189 citing papers, 2.1% of this breakdown
0%29.5%Other 22.6%

Fields

  • Medicine61.9%
  • Neuroscience21.3%
  • Biochemistry, Genetics and Molecular Biology11.8%
  • Immunology and Microbiology1.4%
  • Engineering1.2%
  • Materials Science0.5%
  • Other1.9%

Topics

  • Acute Ischemic Stroke Management15%
  • Neuroinflammation and Neurodegeneration Mechanisms6.8%
  • Intracerebral and Subarachnoid Hemorrhage Research4.4%
  • Cerebrovascular and Carotid Artery Diseases4.2%
  • Stroke Rehabilitation and Recovery3.8%
  • Barrier Structure and Function Studies3.4%
  • Other62.4%

Coauthors

All papers

Open in search
  1. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2014 cited by 2,723

  2. Thrombolysis for acute ischaemic stroke

    Authors: , , , - Cochrane Database of Systematic Reviews 2009 cited by 1,370

  3. Angiogenesis in the ischemic core: A potential treatment target?

    Authors: , , , , , - Journal of Cerebral Blood Flow & Metabolism 2019 cited by 151

  4. Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator

    Authors: , , , - Stroke 2009 cited by 825

  5. Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage

    Authors: , , , , , , , , , , , , - Neurocritical Care 2015 cited by 691

  6. Comparison of Large Animal Models for Acute Ischemic Stroke: Which Model to Use?

    Authors: , , , , , , , , , , , , , , , , - Stroke 2022 cited by 90

  7. Hemorrhagic Transformation Within 36 Hours of a Cerebral Infarct

    Authors: , , , , , , , , , - Stroke 1999 cited by 758

  8. Immunologic Privilege in the Central Nervous System and the Blood–Brain Barrier

    Authors: , , , , , , , , , , , , , , - Journal of Cerebral Blood Flow & Metabolism 2012 cited by 307

  9. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons.

    Authors: , , , , - Stroke 1991 cited by 758

  10. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome

    Authors: , , , , , , , , , , - BMC Neurology 2004 cited by 487

  11. Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Geoffrey Cohen, Masatoshi Koga, Jean‐Marc Olivot, Mark Parsons, Barbara C. Tilley, Nils Wahlgren, Gregory J. del Zoppo - Stroke 2016 cited by 252

  12. Heterogeneity in the penumbra

    Authors: , , , - Journal of Cerebral Blood Flow & Metabolism 2011 cited by 175

  13. Role for Matrix Metalloproteinase 9 after Focal Cerebral Ischemia: Effects of Gene Knockout and Enzyme Inhibition with BB-94

    Authors: , , , , , - Journal of Cerebral Blood Flow & Metabolism 2000 cited by 604

  14. Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia

    Authors: , , , , , - Journal of Cerebral Blood Flow & Metabolism 1999 cited by 552

  15. Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial

    Authors: , , , , , , , , , , - The Lancet Neurology 2016 cited by 250

  16. The neurovascular unit in the setting of stroke

    Authors: - Journal of Internal Medicine 2009 cited by 279

  17. Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2016 cited by 236

  18. Microglial Cell Activation is a Source of Metalloproteinase Generation during Hemorrhagic Transformation

    Authors: , , , , , , , , , - Journal of Cerebral Blood Flow & Metabolism 2012 cited by 117

  19. Interendothelial Claudin-5 Expression Depends on Cerebral Endothelial Cell–Matrix Adhesion by β 1 -Integrins

    Authors: , , , , , , , - Journal of Cerebral Blood Flow & Metabolism 2011 cited by 150

  20. Safety and Efficacy of Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Petra Kraayeveld, Geert J. Lycklama à Nijeholt, H. Zwenneke Flach, Michael D. Hill, Jeremy Rempel, Ann M. Lowe, Hester F. Lingsma, Nikki van Leeuwen, Daan Nieboer, Gregory J. del Zoppo, D.C. Rijken, Adam F. Cohen, Victor Gurewich, Lucas Smagge, Stefan D. Roosendaal, Alida A. Postma, Lonneke S.F. Yo, G. Menno Krietemeijer, Martin Sterrenberg, Naziha el Ghannouti, Debby Priem, Monique Batenburg, Eva Ponjee, Rieke Eilander, Joke de Meris, Tamara Dofferhoff-Vermeulen, Sanne J. den Hartog, Stijn Kremer, Sven P. R. Luijten, Leontien Heiligers, Angela Lansbergen-Engel, Karin Jager - JAMA Neurology 2023 cited by 19

  21. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke

    Authors: , , , , , , , , , , , , , , , , , , - Annals of Neurology 1992 cited by 1,003

  22. Focal Cerebral Ischemia Induces Active Proteases That Degrade Microvascular Matrix

    Authors: , , , , , - Stroke 2004 cited by 273

  23. Inflammation and the neurovascular unit in the setting of focal cerebral ischemia

    Authors: - Neuroscience 2008 cited by 244

  24. Microglial Activation and Matrix Protease Generation During Focal Cerebral Ischemia

    Authors: , , , , , , - Stroke 2007 cited by 236